Ballard Partners will report $14 million in lobbying revenues for the first three months of 2025 — a huge surge in business.

Lobbying firms have continued to hoover up new business from colleges and universities as the White House escalates its war ...

Manitoba Drug Formulary Glossary of Terms EDS Certain drugs are approved for coverage under the Exception Drug Status (EDS) Program when the use meets specific criteria as recommended by the Manitoba ...

A bill to prohibit pharmacy benefit managers (PBMs) from owning pharmacies in Arkansas comfortably cleared the Senate on ...

She also oversees a hospital-based student program and co-heads the Antibiotic Stewardship program and the Pharmacy and Therapeutics Committee. Allergic asthma is the most common type of asthma, ...

Lupin Digital Health, drugmaker Lupin's digital therapeutics arm that focuses on cardiac rehabilitation and care, has doubled its patient base to 10,000 in the past year and expects to grow ...

She was on the ethics committee as well as the pharmacy and therapeutics committee. Jackson served one year as chief medical officer and interim vice president of medical affairs. In this role ...

REDWOOD CITY, Calif., April 8, 2025 /PRNewswire/ -- Synthego and Vita Therapeutics, Inc. today announced a licensing agreement to integrate Synthego's high-fidelity hfCas12Max CRISPR system into ...

The Senate Committee on Insurance and Commerce approved legislation Tuesday to ban pharmacy benefit managers from owning pharmacies. Subscribe to continue reading, or log in . Neal Earley ...

Full biographies for Newleos’ leadership team are available on the Newleos website. About Newleos Therapeutics, Inc. Newleos Therapeutics is dedicated to providing a new dawn or "eos" for patients ...

Baynes to the Board and John Northcott as chief commercial officer Well capitalized with cash and marketable securities of $549.7 million SAN FRANCISCO, April 08, 2025 (GLOBE NEWSWIRE) -- Nurix ...